↓ Skip to main content

Evaluation of the impact of immediate versus WHO recommendations-guided antiretroviral therapy initiation on HIV incidence: the ANRS 12249 TasP (Treatment as Prevention) trial in Hlabisa sub-district…

Overview of attention for article published in Trials, July 2013
Altmetric Badge

Mentioned by

news
1 news outlet
twitter
5 X users

Readers on

mendeley
399 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Evaluation of the impact of immediate versus WHO recommendations-guided antiretroviral therapy initiation on HIV incidence: the ANRS 12249 TasP (Treatment as Prevention) trial in Hlabisa sub-district, KwaZulu-Natal, South Africa: study protocol for a cluster randomised controlled trial
Published in
Trials, July 2013
DOI 10.1186/1745-6215-14-230
Pubmed ID
Authors

Collins C Iwuji, Joanna Orne-Gliemann, Frank Tanser, Sylvie Boyer, Richard J Lessells, France Lert, John Imrie, Till Bärnighausen, Claire Rekacewicz, Brigitte Bazin, Marie-Louise Newell, François Dabis, ANRS 12249 TasP study group

Abstract

Antiretroviral therapy (ART) suppresses HIV viral load in all body compartments and so limits the risk of HIV transmission. It has been suggested that ART not only contributes to preventing transmission at individual but potentially also at population level. This trial aims to evaluate the effect of ART initiated immediately after identification/diagnosis of HIV-infected individuals, regardless of CD4 count, on HIV incidence in the surrounding population. The primary outcome of the overall trial will be HIV incidence over two years. Secondary outcomes will include i) socio-behavioural outcomes (acceptability of repeat HIV counselling and testing, treatment acceptance and linkage to care, sexual partnerships and quality of life); ii) clinical outcomes (mortality and morbidity, retention into care, adherence to ART, virologic failure and acquired HIV drug resistance), iii) cost-effectiveness of the intervention. The first phase will specifically focus on the trial's secondary outcomes.

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 399 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Canada 2 <1%
United Kingdom 1 <1%
Australia 1 <1%
Belgium 1 <1%
Unknown 394 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 82 21%
Researcher 68 17%
Student > Ph. D. Student 51 13%
Student > Bachelor 22 6%
Student > Doctoral Student 17 4%
Other 69 17%
Unknown 90 23%
Readers by discipline Count As %
Medicine and Dentistry 132 33%
Nursing and Health Professions 42 11%
Social Sciences 35 9%
Pharmacology, Toxicology and Pharmaceutical Science 10 3%
Agricultural and Biological Sciences 9 2%
Other 54 14%
Unknown 117 29%